RALPH SNYDERMAN
CIK 1178031 · last filed 2025-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.85M
Companies
6
Total Filings
88
Lifetime Open-Market Net
-$2.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRTC | Director | 13,288 | $113.65 | $1.51M | -$97.9K | 13 | 2025-05-29 |
| CDNA | Director | 58,177 | $22.97 | $1.34M | -$1.83M | 44 | 2022-10-04 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 573 | — | — | $0 | 2 | 2017-01-04 |
| Press Ganey Holdings, Inc. (PGND) Delisted | Director | 0 | — | — | $0 | 3 | 2016-10-25 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | $0 | 2 | 2011-12-06 |
| PROCTER & GAMBLE Co (PGw) Delisted | Director | 46,690 | — | — | -$259.7K | 14 | 2010-06-11 |
Recent Filings · Page 7 of 9
88 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-24 | CDNA | Exer (M) | +11,678 | $27.2K | EDGAR |
| 2015-04-03 | CDNA | Grant (A) | +1,440 | $0 | EDGAR |
| 2015-01-05 | CDNA | Grant (A) | +1,417 | $0 | EDGAR |
| 2014-10-03 | CDNA | Grant (A) | +543 | $0 | EDGAR |
| 2014-07-23 | CDNA | Grant (A) | — | $0 | EDGAR |
| 2012-06-08 | — | Grant (A) | — | $0 | |
| 2011-12-06 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Disp (D) | −1,139 | -$37.9K | EDGAR |
| 2011-06-17 | — | Grant (A) | — | $0 | |
| 2011-05-19 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | +1,139 | $0 | EDGAR |
| 2010-06-18 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.